Current Neuropharmacology

Article	Citations
Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management	148
Role of Glycerophospholipid Metabolism in Epilepsy	129
Early Family Intervention for Youth at Risk for Bipolar Disorder: Psychosocial and Neural Mediators of Outcome	106
Redox Modulation of Meniere Disease by Coriolus versicolor Treatment, a Nutritional Mushroom Approach with Neuroprotective Potential	105
The Role of Natural Products in Treatment of Depressive Disorder	93
Effects of β -caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction	90
Local and Remote Chemogenetic Suppression of Hippocampal Seizures in Rats	82
Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS	81
Childhood Trauma and Self-harm in Youths with Bipolar Disorders	80
Mimicking Extracellular Matrix via Engineered Nanostructured Biomaterials for Neural Repair	76
Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinson’s Disease: An Update Since 2017	73
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder	67
Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease	64
Neurocognitive Correlates of Cerebellar Volumetric Alterations in Youth with Pediatric Bipolar Spectrum Disorders and Bipolar Offspring	62
Modulating Ferroptosis: A Novel Approach to Promote Neural Repair in Brain Injury	62
Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study	61
Thematic Selection: Stress and Stress-related Disorders Neurobiology & Translational Aspects of Stress-related Disorders (Part 3)	59
Meet the Editorial Board Member	52
Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis	51
Perspective on the Relationship between GABAA Receptor Activity and the Apparent Potency of an Inhibitor	50
Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase	49
Exploring Mechanistic Insights by Carotenoids in Neuropathic and Inflammatory Pain	49
Unraveling the Role of Perivascular Macrophages in Alzheimer's Disease: Insights from the Crosstalk between Immunometabolism and Ferroptosis	49
The Formyl Peptide Receptor 2 as a Target for Promotion of Resolution of Inflammation	48
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics	47

Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study	47
Microglia-Astrocyte Crosstalk in Post-Stroke Neuroinflammation: Mechanisms and Therapeutic Strategies	46
Antioxidants, Hormetic Nutrition, and Autism	44
Role of Traditional Chinese Medicine Formulations in Reducing Neuroinflammation and Oxidative Stress in Alzheimer’s Disease	44
Unveiling the Potential Neuroprotective Effect of Bioactive Compounds from Plants with Sedative and Mood-Modulating Properties: Innovative Approaches for the Prevention of Alzheimer's and Parkinson's	42
OL-FS13 Alleviates Cerebral Ischemia-reperfusion Injury by Inhibiting miR-21-3p Expression	42
Myeloid-derived Suppressor Cells and Multiple Sclerosis	41
Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials	40
Antiseizure Medications: Advancements, Challenges, and Prospects in Drug Development	39
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy	39
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment	39
The Mechanisms and Application Prospects of Astrocyte Reprogramming into Neurons in Central Nervous System Diseases	38
What is the Role of Lithium in Epilepsy?	38
Meet the Country Editor	37
mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data	37
Corrigendum to: “Effects of Alcohol on EEG Activity: A Systematic Review Focused on Sex-Related Differences in Youth”	35
Role of Microglia in Psychostimulant Addiction	35
Fast Declining Prediction in Alzheimer’s Disease from Early Clinical Assessment	35
Vortioxetine versus SSRI/SNRI with Pregabalin Augmentation in Treatment-Resistant Burning Mouth Syndrome: A Prospective Clinical Trial	34
Resveratrol Supplementation Modulates Endothelial Dysfunction in Alzheimer’s Disease (AD): In Vitro Effects on Human Aortic Endothelial Cells Exposed to AD Plasma	34
Early Enteral Feeding Restores Neurofilament Light Chain Serum Levels in Preterm Newborns	34
Meet the Editorial Board Member	34
Functional and Clinical Relevance of the Crosstalk between the Glymphatic System and the Lymphatic System	32
Is Antipsychotic Drug Use During Pregnancy Associated with Increased Malformation Rates and Worsening of Maternal and Infant Outcomes? A Systematic Review	32
New Insights of Early Brain Injury after Subarachnoid Hemorrhage: A Focus on the Caspase Family	31
The Role of the Microbiota-Gut-Brain Axis in Perinatal Depression: Novel Insights for Treatment	31
How to Optimize the Effectiveness and Safety of Parkinson’s Disease Therapy? – A Systematic Review of Drugs Interactions with Food and Dietary Supplements	31
Daridorexant and Insomnia in Clinical Practice: A Nominal GroupTechnique Consensus Study among Italian Sleep and Insomnia Experts	31
Major Depression in Comorbidity with Substance use Disorders: Patients’ Features and Clinical-Neurobiological Rationale of Antidepressant Treatments	31
Long-term Efficacy and Safety of Sodium Oxybate in Treating Alcohol Use Disorder: A Systematic Review and Meta-Analysis	29
Paraquat and Parkinson’s Disease: The Molecular Crosstalk of Upstream Signal Transduction Pathways Leading to Apoptosis	29
Gut Microbiome in Alzheimer’s Disease: from Mice to Humans	28
The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease	28
Diabetes, Alzheimer's Disease Risk Factors, and the Cafeteria Diet: A Comprehensive Review	28
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease	28
The Emerging Role of Quercetin in the Treatment of Chronic Pain	27
The Role of Epigenetics in the Pathogenesis and Potential Treatment of Attention Deficit Hyperactivity Disorder	27
Meet the Editorial Board Member	27
Alzheimer's Disease May Benefit from Olive Oil Polyphenols: A Systematic Review on Preclinical Evidence Supporting the Effect of Oleocanthal on Amyloid-β Load	27
In Vitro and In Vivo Evaluation of Kai-Xin-San Polysaccharides: Antioxidant, Anti-Inflammatory, and Anti-Alzheimer's Disease Activities	26
Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological Disorders	26
Aryl Hydrocarbon Receptor Establishes a Delicate Balance between the Level of the Trace Amine Tryptamine and Monoamine Oxidase Activity in the Brain and Periphery in Health and Conditions such as Neur	26
Neuroinflammation: The Role of Anthocyanins as Neuroprotectants	26
A Review on Preclinical Models of Ischemic Stroke: Insights Into the Pathomechanisms and New Treatment Strategies	25
Dapsone, More than an Effective Neuro and Cytoprotective Drug	25
The Role of Induced Pluripotent Stem Cells in the Treatment of Stroke	25
Toxic Effects of Methamphetamine on Perivascular Health: Co-morbid Effects of Stress and Alcohol Use Disorders	25
Depression and the Glutamate/GABA-Glutamine Cycle	25
Hydroxychloroquine Prevents High-altitude Cerebral Edema by Inhibiting Endothelial Claudin-5 Autophagic Degradation	25
New Insights on Mechanisms and Therapeutic Targets of Cerebral Edema	24

Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds	24
Pathomechanistic Networks of Motor System Injury in Amyotrophic Lateral Sclerosis	24
Spatiomolecular Characterization of Dopamine D2 Receptors Cells in the Mouse External Globus Pallidus	24
Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer’s Disease: Recent Advances and Therapeutic Implications	24
Emerging Roles of Microglia in Blood-Brain Barrier Integrity in Aging and Neurodegeneration	23
From Phenomes to Genes: Phenotype-based Strategies in Rodents for Research on the Neurobiological and Genetic Bases of Psychiatric-relevant Traits	23
Bibliometric Analysis of Antipsychotic-induced Metabolic Disorder from 2006 to 2021 Based on WoSCC Database	23
Association between Suicidal Ideation and Immune Parameters in First-episode Patients with Schizophrenia	23
Sensory Reinforced Corticostriatal Plasticity	23
Titration of Pharmacological Responses in ICU Patients by Quantified EEG	23
Meet the Section Editor	23
The Dual Role of Microglia in Multiple Sclerosis and its Implications for Diagnostics and Repair	22
The Potential Role of Glutamate Receptors and their Antagonists or Modulators in Migraine Therapy	22
Neonatal Arterial Ischaemic Stroke: Advances in Pathologic Neural Death, Diagnosis, Treatment, and Prognosis	22
Effects of Natural Products on Neuromuscular Junction	21
Bibliometric Analysis of the Research Status and Global Trends in Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease from 2002 to 2022	21
Virtual Screening-Based Drug Development for the Treatment of Nervous System Diseases	21
The Modulatory Effects of Anesthetics and Analgesics onNeurophysiological Monitoring and Underlying Mechanisms	21
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis	21
Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson’s Disease	21
Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial	21
Targeting Estrogen Signaling in the Radiation-induced Neurodegeneration: A Possible Role of Phytoestrogens	21
Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions	20
Structural and Functional MRI Brain Changes in Patients with Schizophrenia Following Electroconvulsive Therapy: A Systematic Review	20
Advances in the Mechanism of ceRNA Regulation in Postoperative Cognitive Dysfunction	20
Machine Learning and Pharmacogenomics at the Time of Precision Psychiatry	20
The Potential Influence of Associated Antidepressants on the Pharmacokinetic Profile of Esketamine in Patients Affected by Treatment-resistant Depression	20
Prospective Investigation of Glutamate Levels and Percentage Gray Matter in the Medial Prefrontal Cortex in Females at Risk for Postpartum Depression	20
Lurasidone vs. Other Antipsychotics as Augmentation Strategies for Clozapine in Treatment-resistant Schizophrenia: An Observational Multicenter Prospective Study	20
Sensorimotor Alterations Induced by Novel Fentanyl Analogs in Mice: Possible Impact on Human Driving Performances	20
Post-Herpetic Neuralgia: Review of Pathophysiology, Mechanisms, and Drug Treatment	20
Current Insights into the Neurotoxicity of Melamine: A Comprehensive Review	20
The Role of Caspase Family in Acute Brain Injury: The Potential Therapeutic Targets in the Future	20
A New Augmentation Strategy against Depression Combining SSRIs and the N-terminal Fragment of Galanin (1-15)	19
Intercellular Communication Pathways in Cerebral Ischemia:Mechanisms, Molecular Insights, and Therapeutic Implications	19
Early-Life Microbiome and Neurodevelopmental Disorders: A Systematic Review and Meta-Analysis	19
Biomaterials for Neurotherapeutics: From Lab Discovery to Clinical Application	19
The Dorsolateral Prefrontal Cortex: A High-level Hub for Allostatic Cardiovascular Control	19
Resilience and Recalibration of Bibliometric Indicators in Neurosciencesand Neuropharmacology Journals After COVID-19: A Longitudinal Rateof Change Analysis Using Mixed-Effects Models	19
Meet the Editorial Board Member	19
Modulation of in vitro Network Activity by Optogenetic Stimulation of Parvalbumin-positive Interneurons During Estrous Cycle	19
Restoring Brain Pathways Involved in Diabetes-Associated Neurocognitive Disorders: The Potential of Dipeptidyl Peptidase 4 Inhibitors as a Therapeutic Strategy	19
The Diverse Network of Brain Histamine in Feeding: Dissect its Functions in a Circuit-Specific Way	18
Cariprazine Augmentation in Treatment-Resistant Bipolar Depression: Data from a Retrospective Observational Study	18
UFMylation: A Potential Modification for Neurological Diseases	18
Interleukin-17A in Alzheimer’s Disease: Recent Advances and Controversies	18
Association of Oxidative Stress with Neurological Disorders	18
An Update on Nondopaminergic Treatments for Motor and Non-motor Symptoms of Parkinson’s Disease	18
Probiotics Decrease C-Reactive Protein Levels in Depression Depending on Metabolic Syndrome Presence or Antidepressant Treatment – Secondary Results of a Randomized Clinical Trial	18
Conventional and Emerging Drug Targeting Sites in Alzheimer’s Disease and the Role of Translational Informatics in its Diagnosis and Management	18
Fabry Disease: Current and Novel Therapeutic Strategies. A Narrative Review	18
Secondary White Matter Injury Mediated by Neuroinflammation after Intracerebral Hemorrhage and Promising Therapeutic Strategies of Targeting the NLRP3 Inflammasome	17
Advances on Epigenetic Drugs for Pediatric Brain Tumors	17
Targeting the Main Sources of Reactive Oxygen Species Production: Possible Therapeutic Implications in Chronic Pain	17
Development of Non-opioid Analgesics Targeting Two-pore Domain Potassium Channels	17
Does the Brain Matter? Cortical Alterations in Pediatric Bipolar Disorder: A Critical Review of Structural and Functional Magnetic Resonance Studies	16
Cholesterol in Brain Development and Perinatal Brain Injury: More than a Building Block	16
The Role of Total White Blood Cell Count in Antipsychotic Treatment for Patients with Schizophrenia	16
Acknowledgements to Reviewers	16
Abusive use of Zolpidem as a Result of COVID-19 and Perspectives of Continuity of the Problem in the Post-Pandemic Period	16
Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease	16
7,8-Dihydroxyflavone and Neuropsychiatric Disorders: A Translational Perspective from the Mechanism to Drug Development	16
Contributions of Zebrafish Studies to the Behavioural Consequences of Early Alcohol Exposure: A Systematic Review	16
The Comprehensive Neural Mechanism of Oxytocin in Analgesia	16
Isolated Mitochondrial Preparations andIn organelloAssays: A Powerful and RelevantEx vivoTool for Assessment of Brain (Patho)physiology	16
Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer’s Disease	16
Vasoactive Intestinal Peptide: A Neuropeptide that Plays an ImportantRole in Parkinson's Disease	15
A Bibliometric and Visual Analysis of Single Nucleotide Polymorphism Studies in Depression	15
Natural Products-based Drugs: Potential Drug Targets Against Neurological Degeneration	15
Mediterranean Pattern Diet in Multiple Sclerosis: A Review Focusing on Immunometabolites	15
Beyond its Psychiatric Use: The Benefits of Low-dose Lithium Supplementation	15
Determining the Interaction in a Drug Combination using the Dose-based or Effect-based Method	15
Exploring the Effectiveness and Potential Pharmacological Mechanism of Minocycline for Spinal Cord Injury through Meta-Analysis and Network Pharmacology	15
The Fragile Balance: Autophagy's Role in Neurodegenerative DiseaseProgression	15
MicroRNAs as Potential Biomarkers and Therapeutic Targets in Ischemic Stroke from the Perspective of Inflammation	15
Beneficial and Detrimental Effects of Uric Acid on Alzheimer’s Disease	15
How to Modulate Peripheral and Central Nervous System to Treat Acute Postoperative Pain and Prevent Pain Persistence	15
Pathways from the Superior Colliculus to the Basal Ganglia	15
Therapeutic Approaches Interfering with Nuclear Localization Signals: An Emerging Strategy for CNS-Related Diseases	15
Striatal Acetylcholine and Dopamine Interactions Produce Situationappropriate Action Selection	15

Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression	15
Emerging Neurobiological Concepts and Therapies for Neurological Rare Diseases	14
Antidepressant Prescription for Major Depressive Disorder: Results from a Population-Based Study in Italy	14
Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint	14
Central Sensitization and Pain: Pathophysiologic and Clinical Insights	14
Meet the Country Editor	14
Contribution of Drugs to Drowning in Scotland from 1996 to 2020	14
The Natural Protoalkaloid Methyl-2-Amino-3-Methoxybenzoate (MAM) Alleviates Positive as well as Cognitive Symptoms in Rat and Mouse Schizophrenia Models	14
Galectin-3 in Microglia-Mediated Neuroinflammation: Implications for Central Nervous System Diseases	14
Preface	14
Immune System and Methamphetamine: Molecular Basis of a Relationship	14
Meet the Section Editor	14
Epigenetics of Fear, Anxiety and Stress – Focus on Histone Modifications	14
Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder	13
Differing Prevalence and Correlates of Metabolic Syndromes Between Chlorpromazine and Clozapine: A 10-year Retrospective Study of a Male Chinese Cohort	13
Protein Kinases in Alzheimer’s Disease: Pioneering Insights into Pathogenesis and Therapeutic Breakthroughs	13
Neurobehavioral Profiles of Six Genetically-based Rat Models of Schizophrenia- related Symptoms	13
Epilepsy and Cognitive Impairment in Childhood and Adolescence: A Mini-Review	13
Clinical Trials of Non-Coding RNAs as Diagnostic and Therapeutic Biomarkers for Central Nervous System Injuries	13
Neural Networks of Knowledge: Ontologies Pioneering Precision Medicine in Neurodegenerative Diseases	13
Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review	13
Powering Up the Brain: Intercellular Mitochondrial Quality Control andIts Implication in Stroke	13
A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia Gravis	13
Neutrophil Heterogeneity and its Roles in the Inflammatory Network after Ischemic Stroke	13
Epigenetic Mechanisms in the Pathophysiology and Progression of Epilepsy: A Comprehensive Review of Experimental and Clinical Studies	13
Potential Benefits of Quercetin through P2X7 Modulation against Neuroinflammation in Alzheimer's Disease	13
Bipolar Disorder and Manic-Like Symptoms in Alzheimer’s, Vascular and Frontotemporal Dementia: A Systematic Review	13
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study)	13
Therapeutic Potential of Anesthesiology for Sleep Disorders in the Perioperative Period	13
Glucocorticosteroids Effects on Brain Development in the Preterm Infant: A Role for Microglia?	13
Rethinking ‘Innovation’ in Psychiatry with Older and Newer Treatments: From Bench to Benchside	13
Progress in Neuropharmacology of Anesthetics and Analgesics for the Improvement of Medical Treatment	12
Symptoms of Protracted Alcohol Withdrawal in Patients with Alcohol Use Disorder: A Comprehensive Systematic Review	12
Two Distinct Neuronal Populations in the Rat Parafascicular Nucleus Oppositely Encode the Engagement in Stimulus-driven Reward-seeking	12
Promising Perspective to Facioscapulohumeral Muscular Dystrophy Treatment: Nutraceuticals and Phytochemicals	12
The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease	12
Dietary Intervention with Omega-3 Fatty Acids Mitigates Maternal High-Fat Diet-Induced Behavioral and Myelin-Related Alterations in Adult Offspring	12
Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration	12
Anticholinesterases Traits Inbuilt in Buxaceae Plant Extracts against Alzheimer’s Disease	12
Effects of Alcohol on EEG Activity: A Systematic Review Focused on Sex-Related Differences in Youth	12
Olanzapine-Induced Weight Gain and Glycolipid Metabolism Aberrations in First-Episode and Antipsychotic-Naïve Schizophrenia Patients: A Longitudinal Study	12
Neuropathic Pain in Aged People: An Unresolved Issue Open to Novel Drug Approaches, Focusing on Painful Diabetic Neuropathy	12
Meet the Co-Editor	12
The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review	12
Epilepsy and Related Neuropsychiatric Comorbidities: Basic and Clinical Research	12
Microtubule-modulating Agents in the Fight Against Neurodegeneration: Will it ever Work?	12
The Orexin System: A Potential Player in the Pathophysiology of Absence Epilepsy	12
Protective Role of Electroacupuncture Against Cognitive Impairment in Neurological Diseases	12
Meet the Co-Editor	12
The Use of Zebrafish as a Non-traditional Model Organism in Translational Pain Research: The Knowns and the Unknowns	12